Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1821-1831

  Sicat, Jocelyn ^a   Sutkowski, Natalie ^b   Huber, Brigitte T ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; HERV K18; Human endogenous retrovirus; Juvenile rheumatoid arthritis; Pediatric systemic lupus erythematosus; Superantigen

Indexed keywords

ALPHA INTERFERON; DNA 18S; HERV K18 SUPERANTIGEN; SUPERANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN ENDOGENOUS RETROVIRUS; IMMUNOSTIMULATION; JUVENILE RHEUMATOID ARTHRITIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GAMMA-GLOBULINS; HUMANS; IMMUNOTOXINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MELPHALAN; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SUPERANTIGENS;

EID: 24944440667     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001;14:227-50.
2. Zinkernagel RM. Antiinfection immunity and autoimmunity. Ann NY Acad Sci 2002;958:3-6.
3. Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol 2003;11:101-5.
4. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999;17:435-66.
5. Papageorgiou AC, Acharya KR. Microbial superantigens: from structure to function. Trends Microbiol 2000;8:369-75.
6. Macphail S. Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases. Int Rev Immunol 1999;18:141-80.
7. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001;15:579-89.
8. Stauffer Y, Marguerat S, Meylan F, et al. Interferon-alpha-induced endogenous superantigen. A model linking environment and autoimmunity. Immunity 2001;15:591-601.
9. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
10. Ono M. Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol 1986;58:937-44.
11. Tonjes RR, Czauderna F, Kurth R. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol 1999;73:9187-95.
12. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, Lenz J. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol 1999;9:861-8.
13. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 2001;11:1531-5.
14. Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996;9:72-99.
15. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994;371:351-5.
16. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-13.
17. Muir A, Ruan QG, Marron MP, She JX. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes 1999;48:219-22.
18. Adelman MK, Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002;102:107-16.
19. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 2001;98:4634-9.
20. Nakamura A, Okazaki Y, Sugimoto J, Oda T, Jinno Y. Human endogenous retroviruses with transcriptional potential in the brain. J Hum Genet 2003;48:575-81.
21. Perron H, Jouvin-Marche E, Michel M, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal V beta 16 T-lymphocyte activation. Virology 2001;287:321-32.
22. Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 1987;61:2059-62.
23. Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA 1996;93:14759-64.
24. Goedert JJ, Sauter ME, Jacobson LP, et al. High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS. Cancer Epidemiol Biomarkers Prev 1999;8:293-6.
25. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003;22:1528-35.
26. Nelson PN, Lever AM, Smith S, et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunol Invest 1999;28:277-89.
27. Ono M, Yasunaga T, Miyata T, Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol 1986;60:589-98.
28. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the Human Genome Mapping Project Database. J Virol 2000;74:3715-30.
29. Marrack P, Kushnir E, Kappler J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 1991;349:524-6.
30. Acha-Orbea H, Scarpellino L, Shakhov AN, Held W, MacDonald HR. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein. J Exp Med 1992;176:1769-72.
31. Beutner U, Frankel WN, Cote MS, Coffin JM, Huber BT. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci USA 1992;89:5432-6.
32. Blaschke S, Schwarz G, Moneke D, Binder L, Muller G, Reuss-Borst M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000;27:866-73.
33. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25.
34. Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 2003;48:1223-8.
35. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med 1996;184:971-80.
36. Diebold SS, Montoya M, Unger H, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003;424:324-8.
37. Garcia-Sastre A. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect 2002;4:647-55.
38. Grandvaux N, tenOever BR, Servant MJ, Hiscott J. The interferon antiviral response: from viral invasion to evasion. Curr Opin Infect Dis 2002;15:259-67.
39. Taki S. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. Cytokine Growth Factor Rev 2002;13:379-91.
40. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001;294:1540-3.
41. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23.
42. Pascual V, Banchereau J, Palucka AK. The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol 2003;15:548-56.
43. Swain A, Coffin JM. Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation. J Virol 1989;63:3301-6.
44. Swain A, Coffin JM. Mechanism of transduction by retroviruses. Science 1992;255:841-5.
45. Hasuike S, Miura K, Miyoshi O, et al. Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus. J Hum Genet 1999;44:343-7.
46. Takemura S, Braun A, Crowson C, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001;167:1072-80.
47. Weyand CM, Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Ann NY Acad Sci 2003;987:140-9.
48. Geisse S, Scheidereit C, Westphal HM, Hynes NE, Groner B, Beato M. Glucocorticoid receptors recognize DNA sequences in and around murine mammary tumour virus DNA. EMBO J 1982;1:1613-9.
49. Tovar Sepulvede VA, Berdel B, Coffin JM, Reuss FU. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment. Virology 2000;275:98-106.
50. Shodell M, Shah K, Siegal FP. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus 2003;12:222-30.
51. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979;301:5-8.
52. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982;216:429-31.
53. Vallin H, Perers A, Alm GV, Ronnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 1999;163:6306-13.
54. Bengtsson AA, Sturfelt G, Truedsson L, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000;9:664-71.
55. Lanza L, Scudeletti M, Monaco E, et al. Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds. Ann NY Acad Sci 1999;876:193-7.
56. Lanza L, Scudeletti M, Puppo F, et al. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 1996;103:482-90.
57. Scudeletti M, Lanza L, Monaco E, et al. Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation. Ann NY Acad Sci 1999;876:164-79.
58. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003;48:2524-32.
59. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 2001;194:1823-34.